Jonesing At Wal-Mart (JSDA, WMT)

Jones Soda Co. (NASDAQ: JSDA) is soaring this morning on its announcement that Wal-Mart is now authorized to retail its products in the company’s 3,800 domestic stores.  What is interesting is that the shares are moving far more than the net addition, because the announcement says, “The deal increases Jones’ total retail outlet distribution by nearly 10%, and will make the product easily accessible to millions of new consumers.”

Jones has been given three shelf facings for a custom assorted 6-pack of Jones Pure Cane Soda, which includes two bottles each of some of Jones’ most popular flavors â€" Green Apple, Berry Lemonade and Cream Soda.  A wal-Mart and Jones variety pack in other words.

Jones shares are up over 45% around the $1.00 mark today and we have already seen 2.3 million shares trade.  The 52-week range is $0.40 to $1.42 and average daily volume is only about 500,000 shares.  Keep in mind that at one time during the specialty beverage boom that Jones was a double digit stock that went above $10 in 2006… Then it went to $20, and then above $30…

UPDATE 1:20 PM EST: Jones shares are now up 50% at $1.05 but the stock has traded as high as $1.25.  We have seen 4.8 million shares, so we are closing in on a 10X volume day already.

JON C. OGG

Next Week’s TiVo Trade Set-Ups (TIVO, DISH, SATS)

TiVo Inc. (NASDAQ: TIVO) was the daily implosion on Friday.  As noted for stocks to watch next week in our UNUSUAL SUSPECTS at 24/7 Wall Street, the stock was given a death-blow after Dish succeeded in getting the TiVo patent case involving Dish Network Corp. (NASDAQ: DISH) and EchoStar Corp. (NASDAQ: SATS) heard on appeal.  What we wanted to do for the week ahead after the huge volume spike was to come up with a trader take for support and resistance levels based on the current prices and based upon the old prices from before TiVo rallied so much.

Shares went from roughly $18.00 down over 41% to close at $10.16 Friday on more than 57 million shares.  This takes TIVO stock almost right where it was before its huge pop-up on winning the patent case in the first place.

As you can see on the chart here from StockCharts.com, you can forget about the key 50-day and 200-day moving averages offering much of anything.  If there is any takeaway in the moving averages, it is only that the 200-day at $11.97 (which will change each day) matters for resistance.  The 50-day average did not even have 50 sessions at the higher prices, explaining why the line goes straight up.

If you go back a year, it is $11.00 that had been the big pivot point and the hard line of resistance back before it won the patent case the first time around.  Above that was a resistance of $12.00, which coincides with the 200-day average right now.  That 200-day average will likely come down over a nickel a day this week and will then start to bleed off closer to 3 cents a day for another week or so.

As far as support, $10.00 had been a longer-term pivot level for support before its significant pop-up earlier this year.  Then there is a lower level of $8.60 to $9.05, which would be a harder support level than $10.00.  So, on downdrafts, S1- $10.00; S2 $9.05; S3- $8.65…

As far as RSI, stochastics, and MACD ar e concerned, you can probably throw those out the window for at least the next two weeks while this stock finds its own trading range.

As far as stock options, we almost always like to see just what the real volatility traders are pricing in for straddles.  It is almost always too expensive to buy both the PUT and CALL at the closest strike price, but we are looking at the $10 straddle for both MAY. The MAY $10 strike was $0.75 for the CALL and appears to be $0.57 for the PUTS.  With $0.16 of intrinsic value, TiVo stock still would have to rise above $11.32 or go down under $8.68 in the next week for the volatility to trade in MAY to make money.

As far as analyst calls yesterday, Lazard did cut the stock to HOLD from BUY.

An appeals court did set aside TiOo’s previous win against Dish Network Corp. (NASDAQ: DISH) and EchoStar Corp. (NASDAQ: SATS) in the patent case for digital video recorders.  It looks as though the federal circuit court for the U.S. Court of Appeals will review its own March decision.  Dish and EchoStar had changed the DVR technology to avoid infringing on the patents, but the court had ruled that the devices still used TiVo’s technology.  $300 million or more in past damage awards hangs in the balance.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Asiainfo… Dis-Info? (ASIA)

Asiainfo Holdings Inc. (NASDAQ: ASIA) started out ok today, but then things got worse.  And worse.  On no real news dissemination this stock is down 8.2% at $22.18 today and the intra-day trading range is $21.90 to $24.38.  The 52-week range is $15.30 to $32.60.

At 3:00 PM EST we have now crossed the 2 million shares mark, making this double normal volume and then some versus 836K on average for a full day.  This is one of those stocks that rarely if ever makes for a volume spike alert.

Sybase Takeover Chatter (SY, SAP)

Sybase, Inc. (NYSE: SY) saw a major volume explosion and massive price move late in the trading day.  Bloomberg reported that SAP AG (NYSE: SAP) may acquire the company.  Maybe yes, maybe no.  Shares at 3:21 PM EST are up a whopping 51% at $63.00 on well over 6 million shares.  Keep in mind that no formal deal has been announced and this would be a very recent development if the company is bought. Stay tuned.

JON C. OGG

Three Frequent Asked Questions about Sedation Dentistry

=================================================

Once you've experienced sedation dentistry with Dr. Larry Lu at BigSmiles Dental Care located in Surrey, Canada, you'll never be afraid to go to the dental office again.

You'll be sedated just enough to be unaware of the treatment, as if you were relaxing. You'll wake up refreshed, with little or no memory of what was accomplished.

Here are the three most asked questions and their answers:

Q1: Am I a Good Candidate?

A:


You or someone you love love are a candidate for sedation dentistry if you have experienced any of the following?

* High Fear or Anxiety.
* Have had traumatic dental experiences.
* Have very sensitive teeth.
* A gag reflex.
* Extensive dental problems.
* A tight schedule.
* Difficulty in becoming numb.


Q2: What Medication Do You Use in the Office?

A:


You will be given some oral medication (Triazolam or Lorazepam) to take about an hour before you come to the office for your treatment. When you arrive in our relaxed dental office, you will already be feeling drowsy so you must be accompanied by a companion. Upon arrival, you will be escorted to the relaxation room. We will cover you up with a cozy warm blanket and monitor your vital signs at all times, more medication will be given depending on procedures and length of your appointment. When you are totally relaxed and comfortable, we will take care of your dental needs. When we have completed your dental treatment, we will have your companion take you home to enjoy the rest of your relaxing day.



Q3: Does It Really Work?



A:



Most patients report that they feel absolutely nothing and that during their appointments they are relaxed, sleeping and comfortable at all times.


You will not be unconscious. You will be in a deep and relaxed state but will be responsive.

You will be sedated, so you will require a companion to drive you to your appointment and home again after.



One of our team members will be with you or monitoring you at ALL times during your visit with us. We will monitor your vital signs to ensure your safety.



You will literally sleep through your appointment with little or no memory of your visit here. This means that you will have no memory of your experience here including the sounds and smells of the dental office. Those individuals who have difficulty getting numb experience great success when they are asleep.



It is extremely safe. There are no intra-venous tubes or needles and we do not use a general anaesthetic. You take one small pill before your appointment and will be totally relaxed. Difficult and involved dental treatments that would often require several appointments can be completed in one while you are asleep.



Surrey dentist, Dr. Larry Lu, DDS can fix your teeth, restore sore gums, and brighten your smile without discomfort. With sedation dentistry, you'll be able to relax through your appointments.



You can have years of dental treatment done in just a few appointments. No more hiding your smile behind your hand or putting up with pain.




Dr. Larry Lu

Biggest Gainers During the Crash (CKP, CAAS, CLWR, RDEN, HTRN, HNT, KERX, MED, PACR, PPO, TIE, ABCO)

Despite a crash on Thursday, these are some of Thursday’s biggest gainers on the day that are not inverse ETF, not gold, not funds, and not preferred or bond shares.  As of 9:20 AM EST:

Checkpoint Systems Inc. (NYSE: CKP) +10.6% to $20.68

China Automotive Systems Inc. (NASDAQ: CAAS) +5% to $20.29; indicated up 1% this morning.

Clearwire Corporation (NASDAQ: CLWR) +5.7% to $7.99; indicated up 0.75% at $8.05.

Elizabeth Arden Inc. (NASDAQ: RDEN) +5.7%; flat on no volume.

Healthtronics Inc. (NASDAQ: HTRN) +32%; flat on low volume.

Health Net Inc. (NYSE: HNT) +5.8%; DOWN 2.5% at $22.81 early this morning

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) +6.8%; shares down 0.7% at $5.91 on low volume.

Medifast Inc. (NYSE: MED) +7.8%; up almost 1% at $32.87.

Pacer International (NASDAQ: PACR) +10%; flat on low volume.

Polypore International (NYSE: PPO) +15%; up 0.7% at $19.54.

Titanium Metals Corp. (NYSE: TIE) +12%… no ind.

The Advisory Board (NASDAQ: ABCO) +11%; indicated up 2% but on no trading.

JON C. OGG

Myriad Comes Up Way Short (MYGN)

Myriad Genetics Inc. (NASDAQ: MYGN) is getting clipped rather hard this morning despite profits rising about 30%.

Earnings were $0.33 EPS and revenue was up 5% at $90.8 million; Thomson Reuters had estimates at $0.39 EPS on revenue of $97.8 million.  2010 Guidance was $1.30 to $1.35 EPS on revenue of $360 million to $365 million; Thomson Reuters has estimates of $1.50 EPS on revenues of $381.5 million.

The company noted, “…macroeconomic conditions continued to impact the frequency of physician visits, which remain well below historic levels…”

Shares were down about 23% on last look in the after-hours session, while the stock at 8:28 AM EST this morning is trading down by 24% at $18.32 on only about 140,000 shares.

Go ahead and mark this as a 52-week low… The prior 52-week range was $20.62 to $38.43.

JON C. OGG

InterMune Implosion (ITMN)

InterMune Inc. (NASDAQ: ITMN) just imploded after-hours.  The stock has traded now over 14 million shares listed as of 5:31 PM EST and the 5.4% drop to $45.44 during the regular session looks like kids play.

• FULL NEWS AT BIOHEALTHINVESTOR.COM

Now shares are down 78% at $9.58 and we saw prints down even around $9.00.  That is close to $2 billion in market cap destroyed in the after-hours session. Mark that as a new 52-week low as the prior range was $10.48 to $49.46.

Ugly, and fugly for that matter, just took on a new name.  That name is InterMune.

JON C. OGG

Popular Gap Reversal (BPOP)

Popular, Inc. (NASDAQ: BPOP) was trading up again and continued up after the gains on Friday evening, but the stock exhibited a true gap & crap pattern after the open.  As covered in The Unusual Suspects this weekend… It has already been a winner with shares up big in the last 3 months.  Shares rose by 8.6% to $4.29 in the after-hours session on more than 900,000 shares Friday on the news: Westernbank Puerto Rico was seized by the FDIC on Friday with about $11.9 billion in assets; Banco Popular agreed to acquire Westernbank’s deposits and about $9.4 billion of its assets, with the FDIC keeping the rest for future sale.

Shares opened at $4.10 after a $3.95 close… At 9:37 AM EST we now have shares DOWN 3.3% at $3.83 on almost 9 million shares.

Shares closed at $3.95 Friday and were up 5% at $4.15 on just over 1 million shares right before the open.  The old 52-week high is $4.23, so this could mark a 52-week high if any added strength returns.

JON C. OGG

Biosante Back on Prostate Cancer Path (BPAX)

Biosante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up after announcing that development of its GVAX Prostate Cancer Vaccine has been reinitiated. The company said that manufacturing of the new GVAX Prostate is in process and that regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken.  Further noted was that prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins.

The stock closed at $2.35 on Friday and at 8:44 AM EST we have shares up over 7% at $2.52 on about 73,000 shares.

JON OGG